> Researchers from the UK and Belgium used publicly available data to estimate how much, on average, drug companies spend on research and development to bring a new medicine to market.
Most prior analyses have been based on confidential data voluntarily supplied by drug companies to researchers with financial ties to the industry. Independent teams have not been able to verify these findings.
The researchers behind this new study estimated that the median cost of bringing a new drug to market was $985 million, and the average cost was $1.3 billion. This is in stark contrast to previous st…